Literature DB >> 26438462

Emergency Neurological Life Support: Status Epilepticus.

Jan Claassen1, James J Riviello2, Robert Silbergleit3.   

Abstract

Patients with prolonged or rapidly recurring convulsions lasting more than 5 min are in status epilepticus (SE) and require immediate resuscitation. Although there are relatively few randomized clinical trials, available evidence and experience suggest that early and aggressive treatment of SE improves patient outcomes, for which reason this was chosen as an Emergency Neurological Life Support protocol. The current approach to the emergency treatment of SE emphasizes rapid initiation of adequate doses of first-line therapy, as well as accelerated second-line anticonvulsant drugs and induced coma when these fail, coupled with admission to a unit capable of neurological critical care and electroencephalography monitoring. This protocol will focus on the initial treatment of SE but also review subsequent steps in the protocol once the patient is hospitalized.

Entities:  

Keywords:  Anticonvulsant; EEG monitoring; Pharmacologic coma; Protocol; Seizures; Status epilepticus

Mesh:

Year:  2015        PMID: 26438462     DOI: 10.1007/s12028-015-0172-3

Source DB:  PubMed          Journal:  Neurocrit Care        ISSN: 1541-6933            Impact factor:   3.210


  32 in total

Review 1.  Status epilepticus.

Authors:  D H Lowenstein; B K Alldredge
Journal:  N Engl J Med       Date:  1998-04-02       Impact factor: 91.245

2.  Short-term mortality after a first episode of status epilepticus.

Authors:  G Logroscino; D C Hesdorffer; G Cascino; J F Annegers; W A Hauser
Journal:  Epilepsia       Date:  1997-12       Impact factor: 5.864

3.  Continuous EEG monitoring and midazolam infusion for refractory nonconvulsive status epilepticus.

Authors:  J Claassen; L J Hirsch; R G Emerson; J E Bates; T B Thompson; S A Mayer
Journal:  Neurology       Date:  2001-09-25       Impact factor: 9.910

4.  Intramuscular versus intravenous therapy for prehospital status epilepticus.

Authors:  Robert Silbergleit; Valerie Durkalski; Daniel Lowenstein; Robin Conwit; Arthur Pancioli; Yuko Palesch; William Barsan
Journal:  N Engl J Med       Date:  2012-02-16       Impact factor: 91.245

5.  National Hospital Ambulatory Medical Care Survey: 2006 emergency department summary.

Authors:  Stephen R Pitts; Richard W Niska; Jianmin Xu; Catharine W Burt
Journal:  Natl Health Stat Report       Date:  2008-08-06

6.  Patients visiting the emergency room for seizures: insurance status and clinic follow-up.

Authors:  Fariba Farhidvash; Pradumna Singh; Bassel Abou-Khalil; Amir Arain
Journal:  Seizure       Date:  2009-09-23       Impact factor: 3.184

7.  Treatment of status epilepticus: a prospective comparison of diazepam and phenytoin versus phenobarbital and optional phenytoin.

Authors:  D M Shaner; S A McCurdy; M O Herring; A J Gabor
Journal:  Neurology       Date:  1988-02       Impact factor: 9.910

8.  Status epilepticus at an urban public hospital in the 1980s.

Authors:  D H Lowenstein; B K Alldredge
Journal:  Neurology       Date:  1993-03       Impact factor: 9.910

9.  Determinants of mortality in status epilepticus.

Authors:  A R Towne; J M Pellock; D Ko; R J DeLorenzo
Journal:  Epilepsia       Date:  1994 Jan-Feb       Impact factor: 5.864

10.  Seizure visits in US emergency departments: epidemiology and potential disparities in care.

Authors:  Daniel J Pallin; Joshua N Goldstein; Jon S Moussally; Andrea J Pelletier; Alexander R Green; Carlos A Camargo
Journal:  Int J Emerg Med       Date:  2008-06-05
View more
  7 in total

1.  Clinical characteristics and outcomes between children and adults with anti-N-Methyl-D-Aspartate receptor encephalitis.

Authors:  Qi Huang; Yuan Wu; Rongfa Qin; Xing Wei; Meigang Ma
Journal:  J Neurol       Date:  2016-09-15       Impact factor: 4.849

2.  Independent impact of infections on the course and outcome of status epilepticus: a 10-year cohort study.

Authors:  Saskia Semmlack; Sarah Tschudin-Sutter; Andreas F Widmer; Martina Valença; Stephan Rüegg; Stephan Marsch; Raoul Sutter
Journal:  J Neurol       Date:  2016-05-03       Impact factor: 4.849

3.  Newer Antiepileptic Drugs in Status Epilepticus: Prescription Trends and Outcomes in Comparison with Traditional Agents.

Authors:  Isabelle Beuchat; Jan Novy; Andrea O Rossetti
Journal:  CNS Drugs       Date:  2017-04       Impact factor: 5.749

Review 4.  Management of the Pediatric Neurocritical Care Patient.

Authors:  Christopher M Horvat; Haifa Mtaweh; Michael J Bell
Journal:  Semin Neurol       Date:  2016-12-01       Impact factor: 3.420

5.  Twitter Journal Club Impact on Engagement Metrics of the Neurocritical Care Journal.

Authors:  Aarti Sarwal; Masoom Desai; Pallavi Juneja; Joni K Evans; Abhay Kumar; Eelco Wijdicks
Journal:  Neurocrit Care       Date:  2022-03-02       Impact factor: 3.532

Review 6.  Newer Antiepileptic Drugs for Status Epilepticus in Adults: What's the Evidence?

Authors:  Isabelle Beuchat; Jan Novy; Andrea O Rossetti
Journal:  CNS Drugs       Date:  2018-03       Impact factor: 5.749

7.  Autoimmune Encephalitis at the Neurological Intensive Care Unit: Etiologies, Reasons for Admission and Survival.

Authors:  Gayane Harutyunyan; Larissa Hauer; Martin W Dünser; Anush Karamyan; Tobias Moser; Slaven Pikija; Markus Leitinger; Helmut F Novak; Eugen Trinka; Johann Sellner
Journal:  Neurocrit Care       Date:  2017-08       Impact factor: 3.210

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.